Showing 1 - 6 of 6
Persistent link: https://www.econbiz.de/10003965336
Persistent link: https://www.econbiz.de/10011537364
Objective. To understand whether US and Canadian breast, colorectal and prostate cancer screening test utilization is consistent with US and Canadian cancer screening guideline information with respect to the age of screening initiation. Design. Cross-sectional, regression discontinuity....
Persistent link: https://www.econbiz.de/10014178454
U.S. cancer screening guidelines recommend that cancer screening begin for breast cancer at age 40 and for colorectal cancer and prostate cancers at age 50. What are the marginal returns to physician and individual compliance with these cancer screening guidelines? We estimate the marginal...
Persistent link: https://www.econbiz.de/10014179658
Background: Cancer screening guidelines reflect the costs and benefits of population-based screening based on evidence from clinical trials. While most of the existing literature on compliance with cancer screening guidelines only measures raw screening rates in the target age groups, we used a...
Persistent link: https://www.econbiz.de/10014192650
Does health insurance affect health and, if so, via what mechanisms? In this paper, we consider a relatively unexplored area in the economics literature, the effects of health insurance on health in the context of latent undiagnosed disease. Specifically, we use a regression discontinuity (RD)...
Persistent link: https://www.econbiz.de/10014166197